Survival, mortality, and related comorbidities among COVID-19 patients in Saudi Arabia
Authors:
- Mohammad A. Al-GhamdiMAMohammad A. Al-Ghamdi
- Rajaa M. Al-RaddadiRARajaa M. Al-Raddadi
- Iman K. RamadanIRIman K. Ramadan
- Ahmad A. MirzaAMAhmad A. Mirza
- Hanan A. AlsaabHanan A. Alsaab
- Hani F. AlobaidiHAHani F. Alobaidi
- Mohammed Y. Bin HaydMHMohammed Y. Bin Hayd
Open Access
- 13 August 2022
- journal article
- research article
- Published by Armed Forces Medical Services in Saudi Medical Journal
- Vol. 43 (8) , 915-926
Abstract
Objectives: To assess the survival of COVID-19 patients in Saudi Arabia and to investigate possible mortality predictors. Methods: This is a retrospective cohort study involving 248 patients with severe acute respiratory syndrome coronavirus-2 who were admitted to the primary COVID-19 referral hospital in Jeddah between March and June of 2020. Socio-demographic characteristics, comorbidities, laboratory investigations, management protocols, complications, treatment options, and mortality data were extracted from electronic medical records. The time analysis began at the first signs of illness thorough discharge or death. Results: Our study showed that in-hospital complications including heart failure followed by acute renal failure had the largest effect size on mortality (pp=0.05). We did not find a significant benefit in relation to any treatment option. Conclusion: Age, asthma, some in-hospital complications are important survival indicators in hospitalized COVID-19 patients. The controllable co-factors should be monitored and managed by healthcare workers to reduce mortality rates in those hospitalized with COVID-19.Keywords
This publication has 28 references indexed in Scilit:
- Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19American Journal of Respiratory and Critical Care Medicine, 2020
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19New England Journal of Medicine, 2020
- Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysisProgress in Cardiovascular Diseases, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective studyBMJ, 2020
- Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysisEuropean Respiratory Journal, 2020
- Time Trends and Regional Variation in Prevalence of Asthma and Associated Factors in Saudi Arabia: A Systematic Review and Meta-AnalysisBioMed Research International, 2018
- Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS)Thorax, 2003